Rosa damascena and Ginkgo biloba aqueous extracts inhibited Tau phosphorylation and neurodegeneration in vitro and in vivo

سال انتشار: 1401
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 154

فایل این مقاله در 8 صفحه با فرمت PDF قابل دریافت می باشد

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

JR_JHGG-6-1_006

تاریخ نمایه سازی: 1 شهریور 1403

چکیده مقاله:

Background: One of the environmental factors leading to Alzheimer's disease (AD) is traumatic brain injury (TBI). Meanwhile, tau protein hyperphosphorylation is known as one of the mechanisms of AD development. In the present study, the effect of Rosa damascena and Ginkgo biloba aqueous extracts on tau hyperphosphorylation was studied on SH-SY۵Y cell lines and mouse TBI models. Methods: Tau protein hyperphosphorylation was induced in SH-SY۵Y cells using ۱۰ μM retinoic acid (RA). Then, cells were treated with ۵۰۰ and ۱۰۰۰ μg/ml aqueous extracts of Rosa damascena and Ginkgo biloba. Cell viability was studied by MTT test and tau protein hyperphosphorylation was studied by western blot and immunostaining techniques. Also, after the induction of TBI by pneumatic cylinder, mice were treated with ۵۰۰ and ۱۰۰۰ μg/ml aqueous extracts of Rosa damascena and Ginkgo biloba, and the animals were tested for beam balance and walk tests to measure balance and muscle stiffness. Finally, tau protein hyperphosphorylation in the brain was investigated using an immunostaining technique. Results: Both aqueous extracts of Rosa damascena and Ginkgo biloba were able to improve SH-SY۵Y viability. Also, a decrease in phosphorylated tau protein was observed in cells treated with aqueous extracts of Rosa damascena and Ginkgo biloba. Performance improvements in beam balance and walk tests in TBI mice treated with ۱۰۰۰ μg/ml Rosa damascena and Ginkgo biloba aqueous extracts were seen. Also, tau protein phosphorylation was significantly decreased in the brain of TBI rats treated with those aqueous extracts. Conclusion: aqueous extracts of Rosa damascena and Ginkgo biloba have neuroprotective effects and are beneficial in reducing TBI-induced tau protein hyperphosphorylation, and they can prevent tau pathology.

نویسندگان

Mohammad Soheil Maveddat

Department of Biotechnology, Faculty of Advance Science and Technology, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran.

Banafshe Salehi

Department of Biotechnology, Faculty of Advance Science and Technology, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran.

Bahareh Salehi

Department of Cellular Molecular Biology, Faculty of Advance Sciences and Technology, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran.

Elaheh Mousavi

Pharmacology Department, Tehran Medical School, Tehran, Iran.

Ehsan Ehsani

Department of Biology, Roudehen Islamic Azad University, Roudehen, Iran.

Koorosh Shahpasand

Department of Brain and Cognitive Sciences, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology (ACECR), Tehran, Iran.

مراجع و منابع این مقاله:

لیست زیر مراجع و منابع استفاده شده در این مقاله را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود مقاله لینک شده اند :
  • Breijyeh ZKRCRoAsDC, Treatment. Molecules [Internet]. ۲۰۲۰; ۲۵(۲۴) ...
  • Lue L-F, Guerra A, Walker DG. Amyloid Beta and Tau ...
  • Scheff SW, Price DA. Alzheimer's disease-related alterations in synaptic density: ...
  • Haake A, Nguyen K, Friedman L, Chakkamparambil B, Grossberg GT. ...
  • Misrani A, Tabassum S, Yang L. Mitochondrial dysfunction and oxidative ...
  • Chang C-HLC-HLH-Yd-g, Gut Microbiota in Alzheimer’s D. International Journal of ...
  • Fabiani C, Antollini SS. Alzheimer’s disease as a membrane disorder: ...
  • Irwin MR, Vitiello MV. Implications of sleep disturbance and inflammation ...
  • Villemagne VL, Doré V, Burnham SC, Masters CL, Rowe CC. ...
  • Wegmann S, Biernat J, Mandelkow E. A current view on ...
  • Qi Y, Guo L, Jiang Y, Shi Y, Sui H, ...
  • Wang L, Zhou Y, Chen D, Lee TH. Peptidyl-prolyl cis/trans ...
  • Naserkhaki R, Zamanzadeh S, Baharvand H, Nabavi SM, Pakdaman H, ...
  • Hajipour MJ, Santoso MR, Rezaee F, Aghaverdi H, Mahmoudi M, ...
  • Kondo A, Shahpasand K, Mannix R, Qiu J, Moncaster J, ...
  • Zeng K, Li M, Hu J, Mahaman YAR, Bao J, ...
  • Kwon KJ, Lee EJ, Cho KS, Cho D-H, Shin CY, ...
  • Qin Y, Zhang Y, Tomic I, Hao W, Menger MD, ...
  • Chen Y, Wang C, Hu M, Pan J, Chen J, ...
  • Al-Snafi AE. Chemical constituents, pharmacological effects and therapeutic importance of ...
  • Senol F, Orhan I, Kürkçüoğlu M, Khan M, Altintas A, ...
  • Senol FS, Orhan IE, Kurkcuoglu M, Khan MTH, Altintas A, ...
  • Ansari N, Khodagholi F. Natural products as promising drug candidates ...
  • Kondo A, Shahpasand K, Mannix R, Qiu J, Moncaster J, ...
  • Feigin VL, Abajobir AA, Abate KH, Abd-Allah F, Abdulle AM, ...
  • Nakamura K, Zhou XZ, Lu KP. Cis phosphorylated tau as ...
  • Blurton-Jones M, Spencer B, Michael S, Castello NA, Agazaryan AA, ...
  • Salloway S, Sperling R, Fox NC, Blennow K, Klunk W, ...
  • Aliakbari F, Haji Hosseinali S, Khalili Sarokhalil Z, Shahpasand K, ...
  • Rahmani S, Mogharizadeh L, Attar F, Rezayat SM, Mousavi SE, ...
  • Karch CM, Goate AM. Alzheimer’s disease risk genes and mechanisms ...
  • Mohammadi A, Maleki-Jamshid A, Sanooghi D, Milan PB, Rahmani A, ...
  • Cavalli A, Bolognesi ML, Minarini A, Rosini M, Tumiatti V, ...
  • Geun Kim H, Sook Oh M. Herbal medicines for the ...
  • Organization WH. National policy on traditional medicine and regulation of ...
  • Ahlemeyer B, Krieglstein J. Pharmacological studies supporting the therapeutic use ...
  • Fu L-M, Li J-T. A systematic review of single Chinese ...
  • Akhondzadeh S, Noroozian M, Mohammadi M, Ohadinia S, Jamshidi A, ...
  • Choukairi Z, Hazzaz T, Lkhider M, Ferrandez JM, Fechtali T. ...
  • Siqueira IR, Fochesatto C, da Silva AL, Nunes DS, Battastini ...
  • Ge J-F, Qiao J-P, Qi C-C, Wang C-W, Zhou J-N. ...
  • Ahlemeyer B, Krieglstein J. Neuroprotective effects of Ginkgo biloba extract. ...
  • Esfandiary E, Karimipour M, Mardani M, Ghanadian M, Alaei HA, ...
  • Yao Z-x, Drieu K, Papadopoulos V. The Ginkgo biloba extract ...
  • Daneshmand P, Saliminejad K, Shasaltaneh MD, Kamali K, Riazi GH, ...
  • Callahan LM, Vaules WA, Coleman PD. Quantitative decrease in synaptophysin ...
  • Ishibashi KI, Tomiyama T, Nishitsuji K, Hara M, Mori H. ...
  • NOURBALA A, AKHOUNDZADEH S. Attention-deficit/hyperactivity disorder: etiology and pharmacotherapy. ۲۰۰۶ ...
  • Singh SK, Srivastav S, Castellani RJ, Plascencia-Villa G, Perry G. ...
  • نمایش کامل مراجع